NCT06591169 Lifestyle Changes in PCOS with OSA and NAFLD
| NCT ID | NCT06591169 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | PCOS |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-07-05 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-07-05 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended
Eligibility Criteria
Inclusion Criteria: * forty women * women complaint PCOS * women complain obstructive sleep apnea * women are obese * women complain fatty liver Exclusion Criteria: * cardiac insult * renal insult * malignacy * pregnancy
Frequently Asked Questions
Who can join the NCT06591169 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 40 Years, studying PCOS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06591169 currently recruiting?
Yes, NCT06591169 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.
Where is the NCT06591169 trial being conducted?
This trial is being conducted at Dokki, Egypt, Dokki, Egypt.
Who is sponsoring the NCT06591169 clinical trial?
NCT06591169 is sponsored by Cairo University. The trial plans to enroll 40 participants.